March 9, 2016 / 7:38 AM / a year ago

BRIEF-Cantargia CAN04 candidate shows good safety in 2nd toxicity study

March 9 (Reuters) - Cantargia AB :

* Has received data from second toxicity study of company's CAN04 product candidate

* No signs of toxicity were observed

* Following finalization of study data has been analyzed and results show that treatment did not give rise to any negative effects

* Is continuing efforts towards clinical study phase Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below